Dowling & Yahnke’s Corteva CTVA Stock Holding History

Dowling & Yahnke’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,300	Closed	-$200K	–	371
2021 Q1	$200K	Buy	+4,300	New	+$190K	0.01%	327

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Dowling & Yahnke's CTVA Position: Q2 2021 in Review

Dowling & Yahnke sold out of Corteva (CTVA) in Q2 2021, closing a stake of 4,300 shares — an estimated $200K sold.

Dowling & Yahnke first reported a position in CTVA in Q1 2021 and held it in 1 quarter. The position peaked at $200K in Q1 2021. 1,040 funds tracked by Wall St. Rank hold CTVA as of Q2 2021.

Dowling & Yahnke reported no remaining Corteva position as of Q2 2021 after selling out during the quarter.
Dowling & Yahnke sold 4,300 Corteva shares in Q2 2021, an estimated $200K.
Dowling & Yahnke first reported a position in Corteva in Q1 2021 and held it in 1 quarter.
Dowling & Yahnke's Corteva position peaked at $200K in Q1 2021.
1,040 funds tracked by Wall St. Rank held Corteva as of Q2 2021.

Based on Dowling & Yahnke's 13F filing for Q2 2021, filed 21 Jul 2021.